Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:60  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

SYMPOSIUM - LIESHMANIASIS

Drug resistance in leishmaniasis

Chakravarty Jaya, Sundar Shyam

Year : 2010| Volume: 2| Issue : 2 | Page no: 167-176

   This article has been cited by
 
1 Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis
M. J. Corral,D. R. Serrano,I. Moreno,J. J. Torrado,M. Dominguez,J. M. Alunda
Journal of Antimicrobial Chemotherapy. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
Shaden Kamhawi,Hamide Aslan,Jesus G. Valenzuela
Frontiers in Public Health. 2014; 2
[Pubmed]  [Google Scholar] [DOI]
3 Discovery of novel anti-leishmanial agents targeting LdLip3 Lipase
Author: Saravanan Parameswaran,Prakash Saudagar,Vikash Kumar Dubey,Sanjukta Patra
Journal of Molecular Graphics and Modelling. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 Co-infection of visceral leishmaniasis and HIV-1: a surviving case in China and review of treatment strategies
Shihui Song,Xi’en Gui,Liren Guan
Emerging Microbes & Infections. 2014; 3(4): e24
[Pubmed]  [Google Scholar] [DOI]
5 Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Advait S. Nagle,Shilpi Khare,Arun Babu Kumar,Frantisek Supek,Andriy Buchynskyy,Casey J. N. Mathison,Naveen Kumar Chennamaneni,Nagendar Pendem,Frederick S. Buckner,Michael H. Gelb,Valentina Molteni
Chemical Reviews. 2014; 114(22): 11305
[Pubmed]  [Google Scholar] [DOI]
6 The effect of furazolidone on the physico-chemical properties of dimyristoylphosphatidylcholine bilayers: Relevance to anti-leishmanial therapy
Victor Hugo Giendruczak Martins,Marisa Raquel Rodrigues,Layoan Dantas Mascarenhas,Carla Roberta Lopes de Azambuja,Julian Londoño Londoño,Vânia Rodrigues de Lima
Journal of Molecular Structure. 2014; 1059: 225
[Pubmed]  [Google Scholar] [DOI]
7 Vaccines to prevent leishmaniasis
Rajiv Kumar,Christian Engwerda
Clinical & Translational Immunology. 2014; 3(3): e13
[Pubmed]  [Google Scholar] [DOI]
8 The severity of cutaneous leishmaniasis before and after the earthquake in Bam, southeastern Iran
Iraj Sharifi,Mohammad Reza Aflatoonian,Behnaz Aflatoonian,Alireza Kermanizadeh
Journal of Parasitic Diseases. 2014;
[Pubmed]  [Google Scholar] [DOI]
9 ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures
D. Mehta,P. Anand,V. Kumar,A. Joshi,D. Mathur,S. Singh,A. Tuknait,K. Chaudhary,S. K. Gautam,A. Gautam,G. C. Varshney,G. P. S. Raghava
Database. 2014; 2014(0): bau051
[Pubmed]  [Google Scholar] [DOI]
10 The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo
Sourav Saha,Tulika Mukherjee,Sayan Chowdhury,Amartya Mishra,Somenath Roy Chowdhury,Parasuraman Jaisankar,Sibabrata Mukhopadhyay,Hemanta K. Majumder
Biochemical Pharmacology. 2013;
[Pubmed]  [Google Scholar] [DOI]
11 Clinical aspects of visceral leishmaniasis in HIV infection
Joseph N. Jarvis,Diana N. Lockwood
Current Opinion in Infectious Diseases. 2013; 26(1): 1
[Pubmed]  [Google Scholar] [DOI]
12 In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes
Shahram Khademvatan,Neda Adibpour,Alborz Eskandari,Saeed Rezaee,Mahmoud Hashemitabar,Fakher Rahim
Experimental Parasitology. 2013; 135(2): 208
[Pubmed]  [Google Scholar] [DOI]
13 Leishmania donovani-specific 25- and 28-kDa urinary proteins activate macrophage effector functions, lymphocyte proliferation and Th1 cytokines production
Vinod Kumar,Jalaj K. Gour,Nisha Singh,Surabhi Bajpai,Rakesh K. Singh
Parasitology Research. 2013; 112(4): 1427
[Pubmed]  [Google Scholar] [DOI]
14 Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani
Sudipta Hazra,Subhalakshmi Ghosh,Madhushree Das Sarma,Smriti Sharma,Mousumi Das,Prakash Saudagar,Vijay Kumar Prajapati,Vikash Kumar Dubey,Shyam Sundar,Banasri Hazra
Experimental Parasitology. 2013; 135(2): 407
[Pubmed]  [Google Scholar] [DOI]
15 Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar
P. Malaviya,E. Hasker,R. P. Singh,J. P. Van Geertruyden,M. Boelaert,S. Sundar
Tropical Medicine & International Health. 2013; 18(2): 188
[Pubmed]  [Google Scholar] [DOI]
16 Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1
B. Mukherjee,R. Mukhopadhyay,B. Bannerjee,S. Chowdhury,S. Mukherjee,K. Naskar,U. S. Allam,D. Chakravortty,S. Sundar,J.-C. Dujardin,S. Roy
Proceedings of the National Academy of Sciences. 2013; 110(7): E575
[Pubmed]  [Google Scholar] [DOI]
17 Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani
Puneet Raina,Sukhbir Kaur
Molecular and Cellular Biochemistry. 2012; 359(1-2): 135
[Pubmed]  [Google Scholar] [DOI]
18 Flow cytometry technique for analysingLeishmaniapromastigote phagocytosis by human polymorphonuclear leucocytes and monocytes
K. REBBESTAD,S. HERREDSVELA,S. SORNES,G. E. EIDE,K. E. MÜLLER,E. SPRIET,H. SJURSEN,A. NAESS
Parasite Immunology. 2012; 34(11): 528
[Pubmed]  [Google Scholar] [DOI]
19 Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues
Rajiv Kumar Verma,Vijay Kumar Prajapati,Girijesh Kumar Verma,Deblina Chakraborty,Shyam Sundar,Madhukar Rai,Vikash Kumar Dubey,Maya Shankar Singh
ACS Medicinal Chemistry Letters. 2012; 3(3): 243
[Pubmed]  [Google Scholar] [DOI]
20 Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis
A. Fortin,S. Hendrickx,V. Yardley,P. Cos,H. Jansen,L. Maes
Journal of Antimicrobial Chemotherapy. 2012; 67(11): 2707
[Pubmed]  [Google Scholar] [DOI]
21 Plant derived therapeutics for the treatment of Leishmaniasis
Rupashree Sen,Mitali Chatterjee
Phytomedicine. 2011; 18(12): 1056
[Pubmed]  [Google Scholar] [DOI]
22 Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Arun Kumar Haldar,Pradip Sen,Syamal Roy
Molecular Biology International. 2011; 2011: 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008